Xortx Therapeutics Inc. (XRTX)
Market Closed
12 Jun, 20:00
CA$
3. 20
0
0%
CA$
- Market Cap
- P/E Ratio
- Div Yield
100 Volume
- Eps
CA$ 3.2
Previous Close Want to track XRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xortx Therapeutics Inc. (XRTX) Statistics
Valuation metrics
Market Cap -
Enterprise value 401.79K
Trailing P/E (ttm) -1.16
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 2.48
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 187
Average volume (90 days) 1.56K
Price summary
52-Week low 2.42
52-Week high 9.85
Beta -
50-Day moving average 3.33
200-Day moving average 3.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 27 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.28%
Return on equity -1.35%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.98
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 0.43%
Book value per share (mrq) 0.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
